We enjoy to work in close partnership with our clients to secure market access. Have a look at some of the many clients we have supported over the years
Wickstrøm & Langkilde ApS was founded in 2008. With the emerging need to provide clinical and economic evidence as a pre-requisite for obtaining market access, we saw the potential for dedicated, specialized services in this field. Our focus from the start was to service all Nordic markets.
Jannie Wickstrøm brings excellence in project management and expert consultancy in the field of health economics and pharmaceutical reimbursement. Before founding Wickstrøm & Langkilde, Jannie Wickstrøm was a Senior Consultant and project leader in the former MUUSMANN Research & Consulting with focus on the Nordic reimbursement systems, economic analysis, and design and operation of evaluation studies in the Danish social and health care system. She has a track record of successful reimbursement submission on behalf of clients in all of the Nordic Countries. She has experience working in a range of therapeutic areas including immunology, neurology, cardiovascular disease, gastrointestinal diseases, endocrinology, hepatology, urology, dermatology, transplantation and oncology.
Jannie has international experience from The World Bank, where she worked with health economics in Asia.
Jannie holds an MS.c. in Economics from University of Odense.
Lars K. Langkilde brings 10 years of experience from global pharmaceutical industry where he held various project and line management positions in clinical development. He has a track record from business important projects as Health Economic Director and Value Demonstration Leader. He has designed major value demonstration programmes in clinical development and for major brands including clinical practice studies, reimbursement studies and epidemiological and economic models. He has experience working in a range of therapeutic areas including cardiovascular disease and thrombosis, gastrointestinal diseases, immunology, hematology, endocrinology, hepatology, immunosuppresive therapy, urology, and oncology.-
Lars has consulting experience from the former MUUSMANN Research & Consulting where he was a Partner with responsibility for business development in the field of health economics.
Lars has an MS.c. in Economics and Statistics from University of Århus and a Ph.d. in Health Economics from the University of Odense.